Oscar Health, Inc. Stock Prediction and Forecast [OSCR]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 07 Oct 2025, 03:49 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Oscar Health, Inc. Stock Prediction and Forecast [OSCR]](https://i.ytimg.com/vi/aJZrZMF2Hno/hqdefault.jpg)
AI-generated source summary
The analysis focuses on Oscar Health (OSCR) stock. Since September 18, 2025, the system has ranked OSCR as a strong buy candidate, with a score of 7.180. The stock has gained 16.75% since then, with an average daily gain of 1.29%. The stock is in an upward trend. For short-term traders, a pullback to the lower segment of the trend is anticipated. A breakout above the upper trendline at $22.90 would signal stronger upward momentum. The three-month trend suggests a potential change of 36.24%, with possible returns ranging from 13.92% to 39.85%. The analysis has a 12-month trend with 8.02% . The future price may fall between $13.34 and $23.64. The latest daily update indicates a close at $22.31, a 3.00% increase. Trading volume decreased, and a medium risk is given. All the analysts give it a Sell Rating. Fibonacci shows no resistance, and a support of $21.66. Our recommended stop-loss is set at $21.65, or 2.98%. The recommendation is to monitor trading with target opening price at 21.95.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.